Suven Life Sciences - Quaterly Results

10 Nov 2022 Evaluate
The total revenue hovered 270.52% to Rs. 43.87 millions for the September 2022 quarter as against Rs. 11.84 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2022 is Rs. -89.33 millions as compared to Net Loss of Rs. -109.83 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to -72.44% as compared to -97.99% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 43.87 11.84 270.52 79.26 31.90 148.46 118.44 134.78 -12.12
Other Income 2.06 5.03 -59.05 6.42 13.43 -52.20 53.17 77.54 -31.43
PBIDT -72.44 -97.99 -26.07 -138.74 -208.20 -33.36 -313.26 -227.93 37.44
Interest 0.69 1.50 -54.00 1.71 3.03 -43.56 5.30 8.15 -34.97
PBDT -73.13 -99.49 -26.50 -80.45 -174.07 -53.78 -318.56 -236.08 34.94
Depreciation 16.20 10.34 56.67 32.01 20.68 54.79 43.93 43.46 1.08
PBT -89.33 -109.83 -18.67 -112.46 -194.75 -42.25 -362.49 -279.54 29.67
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -53.23 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -53.23 0.00
PAT -89.33 -109.83 -18.67 -112.46 -194.75 -42.25 -362.49 -226.31 60.17
Equity 145.38 127.28 14.22 145.38 127.28 14.22 145.38 127.28 14.22
PBIDTM(%) -165.12 -827.62 -80.05 -175.04 -652.66 -73.18 -264.49 -169.11 56.40

Suven Life Sciences Share Price

166.05 -1.75 (-1.04%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×